REFERENCES
- Nathaniel H R, MD, Marni J F, MD, and Chad R H, MD. FGFR-Related Craniosynostosis Syndromes. Nucleic Acids Res. 2001 September 1; 29(17): 3557–3565.
- Fibroblast growth factor receptor 2; FGFR2 [Internet] Available from: www. http://omim.org/entry/176943
- Jane A, Helen D. B, Pita E, Andrew O. M. W, John K. H. Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand. Human Molecular Genetics, 1998, Vol. 7, No. 9: 1475–1483
- Zehra I, Yasar G. Apert Syndrome: A case report. European Journal of Dentistry (2012;6:110-113)
- Andre O.M W, Sarah F. S, Michael O, Michael D. P, Geraldine J. A, Anthony D. H, Richard D. H, David J. D. Apert syndrome results from localised mutations of FGFR2 and is allelic with Crouzon Syndrome. Nature genetics Vol9, February 1995: 1-4
- Orr-Urtreger A, Bedford MT, Burakova T, Arman E, Zimmer Y, Yayon A, Givol D, Lonai P (August 1993). "Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2)". Dev. Biol. 158 (2): 475–86. doi:10.1006/dbio.1993.1205. PMID 8393815.
- Ariane H, Ulrich J, Ulrich M, Ulrike E, Thomas S. The spectrum of Apert syndrome: phenotype, particularities in orthodontic treatment, and characteristics of orthognathic surgery. Published: 8 February 2007 Head & Face Medicine 2007, 3:10 doi:10.1186/1746-160X-3-10
- Meazzini MC, Mazzoleni F, Caronni E, Bozzetti A: LeFort III advancement osteotomy in the growing child affected by Crouzon's and Apert's syndromes: presurgical and postsurgical growth. J Craniofac Surg 2005, 16:369-377.
- Kaya D, Taner T, Aksu M, Keser EI, Tuncbilek G, Mavili ME. Orthodontic and surgical treatment of a patient with Apert syndrome The Journal Of Contemporary Dental Practice Dec 19, 2012
- NCBI, Human genome overview page. [Internet]. Cited 23 August 2013. Available from:http://www.ncbi.nlm.nih.gov/projects/mapview/maps.cgi?taxid=9606&chr=10&MAPS=genec,ugHs,genes-r&cmd=focus&fill=40&query=uid%28-2146581738%29&QSTR=FGFR2%20
- NCBI:HomoloGene:22566. Gene conserved in Coelomata [Internet]. Cited 2013 23 August. Available from: http://www.ncbi.nlm.nih.gov/homologene/22566
- Lewanda AF, Cohen MM Jr, Hood J, Morsey S, Walters M, Kennedy JL Jr, Jabs EW (1993) Cytogenetic survey of Apert syndrome: Reevaluation of a translocation (2;9)(pl 1.2; q34.2) in patient suggests the breakpoints are not related to the disorder.
- Am J Dis Child 147:1306-1308 Omar A. I, Anna V. E, Alexander N. P, Kai Y, David M. O .Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome. Department of Pharmacology, New York University School of Medicine, New York, NY 10016; and Department of Molecular Biology and Pharmacology, Washington University Medical School, St. Louis, MO April 12, 2001 (received for review March 1, 2001)
- Puneet S, Heather B. M, Erika L. L, James L. P, Mariano A. Garcia-B. Identification of an Intronic Splicing Enhancer Essential for the Inclusion of FGFR2 Exon IIIc*□S Received for publication, January 4, 2008 Published, JBC Papers in Press, February 6, 2008, DOI 10.1074/jbc.M800087200
- Woo-Jin P,' Christiane T, Nancy E. M, Gregory A. M, Julie S. F, Craig D, M. Michael C, Ethylin W J. Analysis of Phenotypic Features and FGFR2 Mutations in Apert Syndrome. Am. J. Hum. Genet. 57:321-328, 1995
- Wheldon, Let al"Medical treatment of craniosynostosis: recombinant Noggin inhibits coronal suture closure in the rat craniosynostosis model." Orthodontics and craniofacial research 12(3): 254-262. (2011).
- Reardon, W., et al "Identification and characterization of an inhibitory fibroblast growth factor receptor 2 (FGFR2) molecule, up-regulated in an Apert Syndrome mouse model." Biochemical journal 436(1): 71-81. 4.. (1994).
- Friesel, R. E. and T. Maciag "Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome." Nature Genetics 8(1): 98-103. 5. (1995).
- Katoh, M."Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction." The FASEB journal 9(10): 919-925. 6. (2009).
- Morriss Kay, G. and A. O. M. Wilkie "FGFR2 abnormalities underlie a spectrum of bone, skin, and cancer pathologies." Journal of investigative dermatology 129(8): 1861-1867. 7. (2005).
- Yeh, E., et al "Growth of the normal skull vault and its alteration in craniosynostosis: insights from human genetics and experimental studies." Journal of anatomy 207(5): 637-653. 8.. (2013).
- D'Amici, S., et al. "Novel molecular pathways elicited by mutant FGFR2 may account for brain abnormalities in Apert syndrome." PLoS ONE 8(4): e60439-e60439. 9. (2013).
- Tanimoto, Y., et al. "Inhibition or activation of Apert syndrome FGFR2 (S252W) signaling by specific glycosaminoglycans." Journal of biological chemistry 281(11): 6924-6930. 12. (2004)
- http://en.wikipedia.org/wiki/Fetoscopy